Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays

Background: Understanding of humoral immune responses in tuberculosis (TB) is gaining interest, since B-cells and antibodies may be important in diagnosis as well as protective immune responses. High-content peptide microarrays (HCPM) are highly precise and reliable for gauging specific antibody res...

Full description

Bibliographic Details
Main Authors: Davide Valentini, Martin Rao, Giovanni Ferrara, Marc Perkins, Ernest Dodoo, Alimuddin Zumla, Markus Maeurer
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971217300188
id doaj-0c217ba533074239896f83861f5a6291
record_format Article
spelling doaj-0c217ba533074239896f83861f5a62912020-11-25T01:11:13ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112017-03-0156C15516610.1016/j.ijid.2017.01.015Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarraysDavide Valentini0Martin Rao1Giovanni Ferrara2Marc Perkins3Ernest Dodoo4Alimuddin Zumla5Markus Maeurer6Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, SwedenDivision of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, SwedenDepartment of Medicine Solna, Karolinska Institutet, Stockholm, SwedenFIND, Geneva, SwitzerlandDivision of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, SwedenCentre for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKCentre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, SwedenBackground: Understanding of humoral immune responses in tuberculosis (TB) is gaining interest, since B-cells and antibodies may be important in diagnosis as well as protective immune responses. High-content peptide microarrays (HCPM) are highly precise and reliable for gauging specific antibody responses to pathogens, as well as autoantigens. Methods: An HCPM comprising epitopes spanning 154 proteins of Mycobacterium tuberculosis was used to gauge specific IgG antibody responses in sera of TB patients from Africa and South America. Open source software for general access to this method is provided. Results: The IgG response pattern of TB patients differs from that of healthy individuals, with the molecular complexity of the antigens influencing the strength of recognition. South American individuals with or without TB exhibited a generally stronger serum IgG response to the tested M. tuberculosis antigens compared to their African counterparts. Individual M. tuberculosis peptide targets were defined, segregating patients with TB from Africa versus those from South America. Conclusions: These data reveal the heterogeneity of epitope-dependent humoral immune responses in TB patients, partly due to geographical setting. These findings expose a new avenue for mining clinically meaningful vaccine targets, diagnostic tools, and the development of immunotherapeutics in TB disease management or prevention.http://www.sciencedirect.com/science/article/pii/S1201971217300188TuberculosisMycobacterium tuberculosisPeptide microarrayImmune recognition surfacesHumoral immune response
collection DOAJ
language English
format Article
sources DOAJ
author Davide Valentini
Martin Rao
Giovanni Ferrara
Marc Perkins
Ernest Dodoo
Alimuddin Zumla
Markus Maeurer
spellingShingle Davide Valentini
Martin Rao
Giovanni Ferrara
Marc Perkins
Ernest Dodoo
Alimuddin Zumla
Markus Maeurer
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
International Journal of Infectious Diseases
Tuberculosis
Mycobacterium tuberculosis
Peptide microarray
Immune recognition surfaces
Humoral immune response
author_facet Davide Valentini
Martin Rao
Giovanni Ferrara
Marc Perkins
Ernest Dodoo
Alimuddin Zumla
Markus Maeurer
author_sort Davide Valentini
title Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
title_short Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
title_full Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
title_fullStr Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
title_full_unstemmed Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
title_sort immune recognition surface construction of mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
1878-3511
publishDate 2017-03-01
description Background: Understanding of humoral immune responses in tuberculosis (TB) is gaining interest, since B-cells and antibodies may be important in diagnosis as well as protective immune responses. High-content peptide microarrays (HCPM) are highly precise and reliable for gauging specific antibody responses to pathogens, as well as autoantigens. Methods: An HCPM comprising epitopes spanning 154 proteins of Mycobacterium tuberculosis was used to gauge specific IgG antibody responses in sera of TB patients from Africa and South America. Open source software for general access to this method is provided. Results: The IgG response pattern of TB patients differs from that of healthy individuals, with the molecular complexity of the antigens influencing the strength of recognition. South American individuals with or without TB exhibited a generally stronger serum IgG response to the tested M. tuberculosis antigens compared to their African counterparts. Individual M. tuberculosis peptide targets were defined, segregating patients with TB from Africa versus those from South America. Conclusions: These data reveal the heterogeneity of epitope-dependent humoral immune responses in TB patients, partly due to geographical setting. These findings expose a new avenue for mining clinically meaningful vaccine targets, diagnostic tools, and the development of immunotherapeutics in TB disease management or prevention.
topic Tuberculosis
Mycobacterium tuberculosis
Peptide microarray
Immune recognition surfaces
Humoral immune response
url http://www.sciencedirect.com/science/article/pii/S1201971217300188
work_keys_str_mv AT davidevalentini immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT martinrao immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT giovanniferrara immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT marcperkins immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT ernestdodoo immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT alimuddinzumla immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
AT markusmaeurer immunerecognitionsurfaceconstructionofmycobacteriumtuberculosisepitopespecificantibodyresponsesintuberculosispatientsidentifiedbypeptidemicroarrays
_version_ 1725172200026144768